- About Us
- Clinical Trials
Available Clinical Trials
- Resources
- Contact Us
A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Treatment Trial
(See required screening study MYELOMATCH)